BSE Live
Oct 01, 15:13Prev. Close
1588.50
Open Price
1649.95
Bid Price (Qty.)
1623.30 (1)
Offer Price (Qty.)
1626.00 (40)
NSE Live
Oct 01, 15:13Prev. Close
1585.90
Open Price
1585.00
Bid Price (Qty.)
1624.30 (4)
Offer Price (Qty.)
1625.90 (36)
Balance Sheet of Eris Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 13.62 | 13.60 | 13.60 | 13.59 | 13.58 | |
Total Share Capital | 13.62 | 13.60 | 13.60 | 13.59 | 13.58 | |
Reserves and Surplus | 2,501.28 | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 | |
Total Reserves and Surplus | 2,501.28 | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 | |
Total Shareholders Funds | 2,514.90 | 2,524.02 | 2,221.88 | 1,918.11 | 1,575.47 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 1,632.64 | 485.94 | 209.47 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 22.97 | 37.27 | 37.50 | 36.79 | 5.80 | |
Long Term Provisions | 57.98 | 40.56 | 31.03 | 28.84 | 29.09 | |
Total Non-Current Liabilities | 1,713.59 | 563.77 | 278.00 | 65.62 | 34.88 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 580.31 | 2,043.51 | 107.40 | 0.00 | 0.00 | |
Trade Payables | 216.08 | 138.84 | 83.07 | 96.77 | 86.71 | |
Other Current Liabilities | 158.29 | 37.43 | 34.84 | 31.68 | 30.88 | |
Short Term Provisions | 39.26 | 41.99 | 58.46 | 37.78 | 26.87 | |
Total Current Liabilities | 993.94 | 2,261.78 | 283.77 | 166.24 | 144.46 | |
Total Capital And Liabilities | 5,222.43 | 5,349.57 | 2,783.66 | 2,150.42 | 1,754.80 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 107.17 | 148.25 | 152.40 | 146.01 | 75.18 | |
Intangible Assets | 2,305.01 | 1,367.31 | 745.41 | 495.99 | 509.14 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 2,412.45 | 1,516.17 | 898.16 | 644.99 | 585.88 | |
Non-Current Investments | 991.27 | 1,618.95 | 966.52 | 678.18 | 480.97 | |
Deferred Tax Assets [Net] | 283.36 | 303.79 | 273.78 | 236.11 | 196.75 | |
Long Term Loans And Advances | 249.11 | 1.04 | 74.94 | 2.82 | 4.95 | |
Other Non-Current Assets | 658.70 | 33.08 | 18.19 | 8.32 | 62.63 | |
Total Non-Current Assets | 4,594.89 | 3,473.02 | 2,231.58 | 1,570.41 | 1,331.17 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 30.01 | 99.55 | 50.40 | |
Inventories | 191.25 | 91.64 | 63.70 | 84.79 | 64.85 | |
Trade Receivables | 236.19 | 239.97 | 229.22 | 137.56 | 113.76 | |
Cash And Cash Equivalents | 92.46 | 1,296.74 | 47.65 | 46.11 | 32.66 | |
Short Term Loans And Advances | 14.01 | 47.28 | 43.23 | 52.21 | 35.16 | |
OtherCurrentAssets | 93.63 | 200.93 | 138.28 | 159.80 | 126.82 | |
Total Current Assets | 627.54 | 1,876.55 | 552.08 | 580.01 | 423.63 | |
Total Assets | 5,222.43 | 5,349.57 | 2,783.66 | 2,150.42 | 1,754.80 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 684.54 | 1,507.02 | 26.23 | 27.23 | 21.21 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 5.08 | 2.30 | 532.70 | 7.30 | 20.10 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 13.44 | 13.44 | 13.44 | 13.44 | 13.44 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.33 | 0.33 | 0.33 | 0.35 | 0.36 | |
Non-Current Investments Unquoted Book Value | 990.94 | 1,618.62 | 966.52 | 677.83 | 480.61 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | 30.01 | 99.55 | 50.40 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher